Aha, is this the paper you looked at Kurt? It mentions some of the stuff I think you mentioned: "a model in which XMRV may contribute to tumorigenicity via a paracrine mechanism." It's also the one I had looked at.
"In the prostate cell line, XMRV integration is characterized by a strong preference for transcription start sites, CpG islands, and DNase-hypersensitive sites, all features that are frequently associated with structurally open transcription regulatory regions of a chromosome. Integration of XMRV is also preferred in actively transcribed genes and gene-dense regions within the chromosome."
So if I understand, it has preferences for a number of *types* of sites, but it does not zoom in to any single site or handful of sites. Maybe that was what you meant, I'm not certain.
In the 2nd to last paragraph they explain the whole paracrine mechanism thing.
Yes, here is a link to the full article:
I think this is a VERY important discussion, but probably should have its own topic, not really about Dr Lombardi anymore. Maybe an XMRV research thread?